«Nadph Oxidase

Below is an extended Nadph Oxidase patents listing. Click here to return to the Nadph Oxidase main in depth entry.

Patents :
US Patent No.	Title
7273614	Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids
7319009	Methods and compositions for identifying receptor effectors
7319160	Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
7320988	Methods of lowering lipid levels in a mammal
7320997	Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
7329529	Ubiqutin proteases
7329657	Indazolyl-substituted pyrroline compounds as kinase inhibitors
7335500	Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose
7338952	Acetylenic compounds useful in treating inflammatory disorders
7345025	Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
7345090	Galenical formulation
7317008	Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
7312250	Fluorine-substituted alkyl phenol compounds and their uses
7312243	Materials and methods for treatment of gastrointestinal disorders
7273716	Methods and compositions for identifying therapeutic compounds with GS-7340 ester hydrolase
7273920	Controlling protein levels in eucaryotic organisms
7276364	Nucleic acids encoding endotheliases, endotheliases and uses thereof
7276491	Anticoagulant and fibrinolytic therapy using p38 MAP kinase inhibitors
7282519	Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
7282625	Method of producing single chain protein in plant cells
7291495	.beta.-Secretase variant
7294652	Autoimmune conditions and NADPH oxidase defects
7294718	Synthesis of a 4-methylthiazole-4(S)-carboxylic acid compound
7304060	Indazolyl-substituted pyrroline compounds as kinase inhibitors
7345091	Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
7347984	Mammalian agmatinase inhibitory substance
7392077	Method for treating a patient at risk of loss of cardiac function by cardiac ischemia
7393942	Nucleic acids encoding mutant forms of Fas ligand
7396659	Inhibitors of nitric oxide synthase to treat type 1 diabetes
7396829	Nitric oxide enhancing diuretic compounds, compositions and methods of use
7407776	Engineered zinc finger proteins for regulation of gene expression
7407784	L-amino acid oxidase with cytotoxic activity from Aplysia punctata
7408050	Modified CpG oligodeoxynucleotide with improved immunoregulatory function
7410975	Small molecule toll-like receptor (TLR) antagonists
7417026	Mobilization of hematopoietic cells
7422886	Method for determining modulation of P110.DELTA. activity
7390870	Immune-enhancing peptides
7384909	Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents
7384655	Preparation of compositions to alleviate inflammation and oxidative stress in a mammal
7348142	Cancer diagnostic panel
7348315	Methods of treating heart failure with modified ATP, ADP and AMP compounds
7358085	Anti-angiogenic methods and compositions
7365178	Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis
7371896	Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
7375133	Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
7378282	Method for measuring hypochlorite ion
7378386	Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives
7381807	Immunostimulatory oligonucleotides and uses thereof
7381824	Quinoline derivatives
7425548	Materials and methods for immune system stimulation

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.